메뉴 건너뛰기




Volumn 112, Issue 10, 2015, Pages 871-886

Diabetic maculopathy;Diabetische Makulopathie

Author keywords

Blindness; Laser coagulation; Macular edema; Steroids; Vascular endothelial growth factor

Indexed keywords

CORTICOSTEROID; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

EID: 84944044572     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-015-0127-2     Document Type: Article
Times cited : (6)

References (44)
  • 1
    • 0031786344 scopus 로고    scopus 로고
    • Diabetes in America: epidemiology and scope of the problem
    • Harris MI (1998) Diabetes in America: epidemiology and scope of the problem. Diabetes Care 21(Suppl 3):C11–C14
    • (1998) Diabetes Care , vol.21 , pp. C11-C14
    • Harris, M.I.1
  • 2
    • 0034628425 scopus 로고    scopus 로고
    • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy
    • o A (2000) The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy. N Engl J Med 342:381–389
    • (2000) N Engl J Med , vol.342 , pp. 381-389
  • 5
    • 0031793875 scopus 로고    scopus 로고
    • The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
    • Klein R, Klein BEK, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801–1815
    • (1998) Ophthalmology , vol.105 , pp. 1801-1815
    • Klein, R.1    Klein, B.E.K.2    Moss, S.E.3    Cruickshanks, K.J.4
  • 6
    • 0022347471 scopus 로고    scopus 로고
    • Photocoagulation for diabetic macular edema
    • (1985) Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol 103:1796–1806
    • Arch Ophthalmol , vol.103 , pp. 1796-1806
  • 7
    • 84863221775 scopus 로고    scopus 로고
    • Stadieneinteilung und Therapie der diabetischen Retinopathie und Makulopathie
    • Nentwich NN, Lemmen KD, Ulbig MW (2010) Stadieneinteilung und Therapie der diabetischen Retinopathie und Makulopathie. Z prakt Augenheilkd 31:491–499
    • (2010) Z prakt Augenheilkd , vol.31 , pp. 491-499
    • Nentwich, N.N.1    Lemmen, K.D.2    Ulbig, M.W.3
  • 9
    • 77952271206 scopus 로고    scopus 로고
    • Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): report 1
    • Michaelides M, Fraser-Bell S, Hamilton R, Kaines A, Egan C, Bunce C, Peto T, Hykin P (2010) Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): report 1. Retina 30(5):781–786
    • (2010) Retina , vol.30 , Issue.5 , pp. 781-786
    • Michaelides, M.1    Fraser-Bell, S.2    Hamilton, R.3    Kaines, A.4    Egan, C.5    Bunce, C.6    Peto, T.7    Hykin, P.8
  • 16
    • 84892595109 scopus 로고    scopus 로고
    • Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab
    • Muether PS, Droege KM, Fauser S (2014) Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab. Br J Ophthalmol 98(2):179–181
    • (2014) Br J Ophthalmol , vol.98 , Issue.2 , pp. 179-181
    • Muether, P.S.1    Droege, K.M.2    Fauser, S.3
  • 18
    • 84873408164 scopus 로고    scopus 로고
    • Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months
    • Arevalo JF, Lasave AF, Wu L, Diaz-Llopis M, Gallego-Pinazo R, Alezzandrini AA, Berrocal MH, Pan-American Collaborative Retina Study Group (PACORES) (2013) Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months. Retina 33(2):403–413
    • (2013) Retina , vol.33 , Issue.2 , pp. 403-413
  • 20
    • 84864444516 scopus 로고    scopus 로고
    • One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema
    • Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS, da Vinci Study Group (2012) One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119(8):1658–1665
    • (2012) Ophthalmology , vol.119 , Issue.8 , pp. 1658-1665
  • 22
    • 78049293726 scopus 로고    scopus 로고
    • Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
    • Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliott D, Campochiaro PA, READ-2 Study Group (2010) Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117(11):2146–2151
    • (2010) Ophthalmology , vol.117 , Issue.11 , pp. 2146-2151
  • 24
    • 79953311138 scopus 로고    scopus 로고
    • The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema
    • Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A, RESTORE study group (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615–625
    • (2011) Ophthalmology , vol.118 , Issue.4 , pp. 615-625
  • 25
    • 84899902749 scopus 로고    scopus 로고
    • Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study
    • Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P, RESTORE Extension Study Group (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121(5):1045–1053
    • (2014) Ophthalmology , vol.121 , Issue.5 , pp. 1045-1053
  • 26
    • 84863401792 scopus 로고    scopus 로고
    • Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE
    • Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789–801
    • (2012) Ophthalmology , vol.119 , Issue.4 , pp. 789-801
  • 27
    • 84885022258 scopus 로고    scopus 로고
    • Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
    • Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ, RIDE and RISE Research Group (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120(10):2013–2022
    • (2013) Ophthalmology , vol.120 , Issue.10 , pp. 2013-2022
  • 28
    • 79955557537 scopus 로고    scopus 로고
    • Intracameral injection of bevacizumab for the treatment of neovascular glaucoma
    • Wolf A, von Jagow B, Ulbig M, Haritoglou C (2011) Intracameral injection of bevacizumab for the treatment of neovascular glaucoma. Ophthalmologica 226(2):51–56
    • (2011) Ophthalmologica , vol.226 , Issue.2 , pp. 51-56
    • Wolf, A.1    von Jagow, B.2    Ulbig, M.3    Haritoglou, C.4
  • 29
    • 84880201329 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy
    • Yang CS, Hung KC, Huang YM, Hsu WM (2013) Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J Ocul Pharmacol Ther 29(6):550–555
    • (2013) J Ocul Pharmacol Ther , vol.29 , Issue.6 , pp. 550-555
    • Yang, C.S.1    Hung, K.C.2    Huang, Y.M.3    Hsu, W.M.4
  • 30
    • 84911979513 scopus 로고    scopus 로고
    • Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema
    • Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP (2014) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132(11):1309–1316
    • (2014) JAMA Ophthalmol , vol.132 , Issue.11 , pp. 1309-1316
    • Sun, J.K.1    Lin, M.M.2    Lammer, J.3    Prager, S.4    Sarangi, R.5    Silva, P.S.6    Aiello, L.P.7
  • 32
    • 10044242430 scopus 로고    scopus 로고
    • Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone
    • Brooks HL Jr, Caballero S Jr, Newell CK, Steinmetz RL, Watson D, Segal MS, Harrison JK, Scott EW, Grant MB (2004) Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122:1801–1807
    • (2004) Arch Ophthalmol , vol.122 , pp. 1801-1807
    • Brooks, H.L.1    Caballero, S.2    Newell, C.K.3    Steinmetz, R.L.4    Watson, D.5    Segal, M.S.6    Harrison, J.K.7    Scott, E.W.8    Grant, M.B.9
  • 34
    • 76549110743 scopus 로고    scopus 로고
    • Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema
    • Kreutzer TC, Al Saeidi R, Kook D, Wolf A, Ulbig MW, Neubauer AS, Haritoglou C (2010) Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica 224(4):258–264
    • (2010) Ophthalmologica , vol.224 , Issue.4 , pp. 258-264
    • Kreutzer, T.C.1    Al Saeidi, R.2    Kook, D.3    Wolf, A.4    Ulbig, M.W.5    Neubauer, A.S.6    Haritoglou, C.7
  • 35
    • 84908118639 scopus 로고    scopus 로고
    • Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
    • Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM, Ozurdex MEAD Study Group (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121(10):1904–1914
    • (2014) Ophthalmology , vol.121 , Issue.10 , pp. 1904-1914
  • 36
    • 84867099927 scopus 로고    scopus 로고
    • Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema
    • Campochiaro PA, Brown DM, Pearson A, Chen S, Boyer D, Ruiz-Moreno J, Garretson B, Gupta A, Hariprasad SM, Bailey C, Reichel E, Soubrane G, Kapik B, Billman K, Kane FE, Green K, FAME Study Group (2012) Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology 119(10):2125–2132
    • (2012) Ophthalmology , vol.119 , Issue.10 , pp. 2125-2132
  • 38
    • 0030997154 scopus 로고    scopus 로고
    • Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus
    • Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478
    • (1997) Ophthalmology , vol.104 , pp. 473-478
    • Hikichi, T.1    Fujio, N.2    Akiba, Y.3    Takahashi, M.4    Yoshida, A.5
  • 39
    • 0029949176 scopus 로고    scopus 로고
    • Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane
    • Harbour JW, Smiddy WE, Flynn HW, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405–413
    • (1996) Am J Ophthalmol , vol.121 , pp. 405-413
    • Harbour, J.W.1    Smiddy, W.E.2    Flynn, H.W.3    Rubsamen, P.E.4
  • 41
    • 0025021149 scopus 로고
    • Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion
    • Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31:284–289
    • (1990) Invest Ophthalmol Vis Sci , vol.31 , pp. 284-289
    • Stefansson, E.1    Novack, R.L.2    Hatchell, D.L.3
  • 42
    • 0035158482 scopus 로고    scopus 로고
    • The role of vitrectomy in the treatment of diabetic macular edema
    • Lewis H (2001) The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 131:123–125
    • (2001) Am J Ophthalmol , vol.131 , pp. 123-125
    • Lewis, H.1
  • 43
    • 0033499697 scopus 로고    scopus 로고
    • Pars plana vitrectomy in diabetic macular edema
    • Ferrari TM, Cardascia N, Durante G (1999) Pars plana vitrectomy in diabetic macular edema. Doc Ophthalmol 97:267–270
    • (1999) Doc Ophthalmol , vol.97 , pp. 267-270
    • Ferrari, T.M.1    Cardascia, N.2    Durante, G.3
  • 44
    • 0034122047 scopus 로고    scopus 로고
    • Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane
    • Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20(2):126–133
    • (2000) Retina , vol.20 , Issue.2 , pp. 126-133
    • Gandorfer, A.1    Messmer, E.M.2    Ulbig, M.W.3    Kampik, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.